Altering protein functional properties through terminal fusions
US7160988B1 · kind B1 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Dec 1, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/8251
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
We disclose isolated terminal fusion polypeptides comprising a soybean glycinin or proglycinin polypeptide operably linked to the peptide of SEQ ID NO:12.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.